|
|
Line 36: |
Line 36: |
|
| |
|
| ===1998 [https://jamanetwork.com/journals/jamadermatology/fullarticle/189304?fbclid=IwAR33gpEktRMf2Q0v5Btl9C5E8gmXw-ZP8_gDFt6sebxUBpXE_WfVt-o-mSw Nicotine for Pyoderma Gangrenosum]=== | | ===1998 [https://jamanetwork.com/journals/jamadermatology/fullarticle/189304?fbclid=IwAR33gpEktRMf2Q0v5Btl9C5E8gmXw-ZP8_gDFt6sebxUBpXE_WfVt-o-mSw Nicotine for Pyoderma Gangrenosum]=== |
| *Two patients with pyoderma gangrenosum treated with topical nicotine 0.5% w/w cetamacrogol formula A cream are described here, both of whom had dramatic clinical resolution of their pyoderma gangrenosum | | *Herein we describe a patient with pyoderma gangrenosum who responded twice to topical nicotine within 4 weeks and 3 months, respectively, without any adverse effects. |
| *[https://scholar.google.com/scholar_url?url=https://jamanetwork.com/journals/jamadermatology/articlepdf/189304/dce8005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=Z2aqX4SnOc2rywTPj5aYDw&scisig=AAGBfm1pz6ffl3a23G__I3APgBLpY6Cofw PDF Version] | | *[https://scholar.google.com/scholar_url?url=https://jamanetwork.com/journals/jamadermatology/articlepdf/189304/dce8005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=Z2aqX4SnOc2rywTPj5aYDw&scisig=AAGBfm1pz6ffl3a23G__I3APgBLpY6Cofw PDF Version] |
| *Citation: Wolf R, Ruocco V. Nicotine for Pyoderma Gangrenosum. Arch Dermatol. 1998;134(9):1071–1072. doi:10.1001/archderm.134.9.1071 | | *Citation: Wolf R, Ruocco V. Nicotine for Pyoderma Gangrenosum. Arch Dermatol. 1998;134(9):1071–1072. doi:10.1001/archderm.134.9.1071 |